Stay updated on Dostarlimab Combo in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dostarlimab Combo in Endometrial Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:31:00.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page instead of the study record content. The new page includes a 403 heading and a Home link, indicating access is blocked.
    Difference
    0.5%
    Check dated 2026-09-29T22:47:57.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study details with a generic error page and site chrome.
    Difference
    18%
    Check dated 2026-09-22T22:48:33.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision tag has been updated from v3.6.6 to v3.7.0. This indicates a new build/patch of the ClinicalTrials.gov page, without affecting the study content or presentation.
    Difference
    0.0%
    Check dated 2026-09-15T20:48:46.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, representing a new version of the page. This update likely reflects minor edits or metadata adjustments rather than a major content change.
    Difference
    0.0%
    Check dated 2026-09-01T18:57:39.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A new NIH grant/contract identifier was added to the study's list of other identifiers, indicating NIH funding attribution for the RUBY trial.
    Difference
    0.0%
    Check dated 2026-08-25T19:57:19.000Z thumbnail image

Stay in the know with updates to Dostarlimab Combo in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.